Pai‐Sheng Chen

2.5k citations
37 papers · 1.8k indexed · h-index 16
Topics
Cancer-related molecular mechanisms research (9 papers)RNA modifications and cancer (9 papers)MicroRNA in disease regulation (7 papers)
Partner nations
TaiwanUnited StatesChina

In The Last Decade

Pai‐Sheng Chen

36 papers receiving 1.8k citations

Peers

Pai‐Sheng Chen
Comparison fields: 5 of 108
  • Molecular Biology 1.4k
  • Cancer Research 783
  • Oncology 244
  • Immunology 126
  • Genetics 121
Replace Feng Jiang with:
Feng Jiang China
Pu Li China
Micol Eleonora Fiori Italy
Xueyan Wang China
Zejuan Li United States
Kristin F. Wilson United States
Mariarosaria D’Errico Italy
Jundong Zhou China
Xiangming Ding China
Pai‐Sheng Chen relative to Feng Jiang China Feng Jiang's profile →
Citations per field
00.5×1.5×
Feng Jiang · 1×
Citations per year

Countries citing papers authored by Pai‐Sheng Chen

Since Specialization
Citations

This map shows the geographic impact of Pai‐Sheng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pai‐Sheng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pai‐Sheng Chen more than expected).

Fields of papers citing papers by Pai‐Sheng Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pai‐Sheng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pai‐Sheng Chen. The network helps show where Pai‐Sheng Chen may publish in the future.

Co-authorship network of co-authors of Pai‐Sheng Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Pai‐Sheng Chen. A scholar is included among the top collaborators of Pai‐Sheng Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pai‐Sheng Chen. Pai‐Sheng Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 5
3 3
4 6
5 15
6 6
7 9
8 96
9 60
10 14
11 58
12 29
13 130
14 15
15 125
16 125
17 168
18 297
19 100
20 81

About Pai‐Sheng Chen

Pai‐Sheng Chen is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 37 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (9 papers), RNA modifications and cancer (9 papers) and MicroRNA in disease regulation (7 papers). The work is most often cited by research in Cancer Research (783 citations), Molecular Biology (1.4k citations) and Oncology (244 citations). Pai‐Sheng Chen has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Min‐Liang Kuo, Gunnar Johansson, Jen-Liang Su, Mien‐Chie Hung, Ming-Yang Wang, Jen-Liang Su, Michael Hsiao, King‐Jen Chang, Shaw‐Jenq Tsai and Kuo‐Tai Hua. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026